Should we use organs from donors with CNS malignacy? More data, still no answer

被引:1
作者
Morrissey, P [1 ]
机构
[1] Rhode Isl Hosp, Providence, RI 02903 USA
关键词
D O I
10.1097/01.TP.0000077418.16072.35
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
引用
收藏
页码:280 / 281
页数:2
相关论文
共 8 条
[1]
Risk of tumor transmission in transplantation from donors with primary brain tumors: An Australian and New Zealand Registry report [J].
Chui, AKK ;
Herbertt, K ;
Wang, LS ;
Kyd, G ;
Hodgeman, G ;
Verran, DJ ;
DeLeon, C ;
Sheil, AGR .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1266-1267
[2]
Medical progress: Brain tumors [J].
DeAngelis, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123
[3]
Kauffman HM, 2000, TRANSPLANTATION, V69, pS114
[4]
Transplant tumor registry: Donors with central nervous system tumors [J].
Kauffman, HM ;
McBride, MA ;
Cherikh, WS ;
Spain, PC ;
Delmonico, FL .
TRANSPLANTATION, 2002, 73 (04) :579-582
[5]
The fate of recipients of organs from donors with diagnosis of primary brain tumor [J].
Pokorna, E ;
Vítko, T .
TRANSPLANT INTERNATIONAL, 2001, 14 (05) :346-347
[6]
PORT F, 2003, ASTS WINT S JAN 24 2
[7]
IMMUNOLOGIC REJECTION OF HUMAN CANCER TRANSPLANTED WITH A RENAL ALLOGRAFT [J].
WILSON, RE ;
HAGER, EB ;
HAMPERS, CL ;
CORSON, JM ;
MERRIL, JP ;
MURRAY, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (09) :479-&
[8]
WILSON RE, 1975, TRANSPLANT P, V7, P327